FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38080111000001107: Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Mar 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1204091000001114 Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1204101000001115 Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Siponimod true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Is a Siponimod 250microgram tablets 120 tablet true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has AMP Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has specific active ingredient Siponimod fumaric acid true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Siponimod false Inferred relationship Existential restriction modifier
Mayzent 0.25mg tablets (Novartis Pharmaceuticals UK Ltd) 120 tablet 10 x 12 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start